tirzepatide single dose Zepbound Vials Online | Zepbound Vials for Weight Loss Tirzepatide Weight Loss Injections |

Research suggests that roughly 25% to 40% of weight lost during GLP-1 therapy may come from lean mass, not just fat

Your provider will work with you at each visit to adjust your plan as your body responds

Overweight (BMI of 27 or higher) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes or high cholesterol

The American Medical Association, American Association of Clinical Endocrinology, and other professional organizations recognize obesity as a chronic disease requiring long-term management, and tirzepatide is intended for ongoing use rather than short-term intervention